Amyotrophic lateral sclerosis (ALS)
Description | Antibodies against calcium-canal-, GM1 (5 – 15 %). Please also refer to section “polyneuropathy” | Additional information | Molecular-genetic evaluation possible |
Description | Antibodies against calcium-canal-, GM1 (5 – 15 %). Please also refer to section “polyneuropathy” | Additional information | Molecular-genetic evaluation possible |